HeartSciences (HSCSW) Other financing activities (2022 - 2025)
HeartSciences' (HSCSW) quarterly Other financing activities came in at -$1.9 million in Q2 2025, down 10826.38% quarter-over-quarter from $17250.0 in Q3 2022.
Powered by 
Analysis
HeartSciences (HSCSW) Other financing activities (2022 - 2025) Analysis & Trends
HeartSciences (HSCSW) has reported Other financing activities for 2 consecutive years, with -$1.9 million the latest figure, recorded in Q2 2025.
- For the quarter ending Q2 2025, Other financing activities changed N/A year-over-year to -$1.9 million; the trailing twelve-month figure through Apr 2025 stood at -$1.9 million (changed N/A YoY), and the FY2024 full-year result was $334249.0, up 1837.68% from the prior year.
- Other financing activities declined to -$1.9 million in Q2 2025 per HSCSW's latest filing, from $17250.0 in the prior quarter.
- Across five years, Other financing activities topped out at $17250.0 in Q3 2022 and bottomed at -$1.9 million in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | GE HealthCare Technologies | 29.78 Bn | 27.67 Bn | 2.18 Bn |
| 2 | Lantheus Holdings | 6.58 Bn | 5.99 Bn | 241.86 Mn |
| 3 | Heartflow | 4.11 Bn | 3.74 Bn | 53.19 Mn |
| 4 | Neogen | 2.60 Bn | 2.41 Bn | 107.80 Mn |
| 5 | Butterfly Network | 1.99 Bn | 1.86 Bn | 23.29 Mn |
| 6 | Ceribell | 921.90 Mn | 792.63 Mn | 25.94 Mn |
| 7 | QuidelOrtho | 886.88 Mn | 763.48 Mn | - |
| 8 | Varex Imaging | 779.06 Mn | 679.86 Mn | 76.70 Mn |
| 9 | Prenetics Global | 338.37 Mn | 279.32 Mn | 30.20 Mn |
| 10 | HeartSciences | 184,567.09 | -1.52 Mn | - |